LAVA Therapeutics NVNASDAQ:LVTX
- LAST PRICE2.8900
- TODAY'S CHANGE (%)-0.0100 (-0.3448%)
- Bid / Lots2.8300/ 4
- Ask / Lots3.1000/ 3
- Open / Previous Close2.8900 / 2.9000
- Day Range
- 52 Week Range
- Volume115,199
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LVTX |
|---|---|---|
| 09:32 ET | 1432 | 2.89 |
| 09:36 ET | 500 | 2.8701 |
| 09:45 ET | 800 | 2.96 |
| 10:03 ET | 200 | 2.94 |
| 10:08 ET | 165 | 2.9731 |
| 10:12 ET | 1499 | 2.9799 |
| 10:14 ET | 10269 | 2.9 |
| 10:15 ET | 425 | 2.925 |
| 10:21 ET | 1700 | 2.885 |
| 10:24 ET | 5119 | 2.9 |
| 10:26 ET | 700 | 2.89 |
| 10:33 ET | 100 | 2.895 |
| 10:37 ET | 950 | 2.9 |
| 10:39 ET | 100 | 2.895 |
| 10:48 ET | 5205 | 2.9 |
| 10:50 ET | 200 | 2.895 |
| 10:51 ET | 100 | 2.895 |
| 11:04 ET | 100 | 2.895 |
| 11:06 ET | 100 | 2.895 |
| 11:09 ET | 14210 | 2.86 |
| 11:11 ET | 300 | 2.88 |
| 11:15 ET | 100 | 2.87 |
| 11:20 ET | 103 | 2.88 |
| 11:22 ET | 400 | 2.89 |
| 11:24 ET | 100 | 2.89 |
| 11:31 ET | 185 | 2.875 |
| 11:45 ET | 1000 | 2.875 |
| 11:47 ET | 500 | 2.88 |
| 11:51 ET | 371 | 2.88 |
| 12:00 ET | 2300 | 2.88 |
| 12:02 ET | 1350 | 2.88 |
| 12:07 ET | 100 | 2.88 |
| 12:32 ET | 1000 | 2.88 |
| 12:36 ET | 100 | 2.875 |
| 12:38 ET | 800 | 2.85 |
| 12:41 ET | 2000 | 2.8699 |
| 12:57 ET | 300 | 2.89 |
| 12:59 ET | 1260 | 2.89 |
| 01:01 ET | 100 | 2.935 |
| 01:03 ET | 9400 | 2.89 |
| 01:10 ET | 200 | 2.885 |
| 01:14 ET | 1000 | 2.88 |
| 01:30 ET | 100 | 2.885 |
| 02:15 ET | 3300 | 2.87 |
| 02:26 ET | 2942 | 2.86 |
| 02:36 ET | 6937 | 2.845 |
| 02:40 ET | 1225 | 2.85 |
| 02:42 ET | 424 | 2.85 |
| 02:44 ET | 1000 | 2.85 |
| 02:45 ET | 1153 | 2.845 |
| 02:47 ET | 1400 | 2.85 |
| 02:49 ET | 1700 | 2.85 |
| 02:51 ET | 500 | 2.85 |
| 02:54 ET | 700 | 2.845 |
| 02:58 ET | 500 | 2.85 |
| 03:00 ET | 100 | 2.85 |
| 03:02 ET | 100 | 2.85 |
| 03:03 ET | 100 | 2.85 |
| 03:05 ET | 300 | 2.845 |
| 03:07 ET | 700 | 2.8499 |
| 03:09 ET | 200 | 2.85 |
| 03:12 ET | 1050 | 2.85 |
| 03:14 ET | 1165 | 2.85 |
| 03:16 ET | 1000 | 2.85 |
| 03:18 ET | 200 | 2.85 |
| 03:20 ET | 500 | 2.845 |
| 03:21 ET | 100 | 2.85 |
| 03:23 ET | 400 | 2.845 |
| 03:25 ET | 300 | 2.85 |
| 03:27 ET | 100 | 2.85 |
| 03:30 ET | 900 | 2.845 |
| 03:32 ET | 800 | 2.85 |
| 03:34 ET | 1695 | 2.85 |
| 03:36 ET | 1399 | 2.845 |
| 03:38 ET | 300 | 2.85 |
| 03:39 ET | 400 | 2.85 |
| 03:41 ET | 100 | 2.85 |
| 03:43 ET | 100 | 2.85 |
| 03:45 ET | 100 | 2.85 |
| 03:48 ET | 502 | 2.8495 |
| 03:50 ET | 1090 | 2.85 |
| 03:52 ET | 900 | 2.88 |
| 03:54 ET | 2200 | 2.89 |
| 03:56 ET | 200 | 2.9 |
| 03:57 ET | 824 | 2.8424 |
| 03:59 ET | 200 | 2.89 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
LAVA Therapeutics NV | 76.2M | -1.8x | --- |
Cue Biopharma Inc | 69.1M | -1.7x | --- |
Kezar Life Sciences Inc | 61.0M | -0.6x | --- |
Kronos Bio Inc | 60.1M | -0.5x | --- |
Atara Biotherapeutics Inc | 85.2M | -0.3x | --- |
Correlate Energy Corp | 58.2M | -3.7x | --- |
Company Information
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Contact Information
- Headquarters
- Yalelaan 60UTRECHT, Netherlands 3584 CM
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Chairman of the Board
- Kapil Dhingra
- President, Chief Executive Officer, Management Director
- Stephen Hurly
- Chief Financial Officer
- Edward Smith
- Executive Vice President Head of Research and Development
- Paul Parren
- Chief Scientific Officer
- Hans Van Der Vliet
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $76.2M |
|---|---|
Revenue (TTM) | $6.8M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.58 |
Book Value | $1.95 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 11.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -638.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
